South Dakota Investment Council raised its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 22.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 90,333 shares of the company’s stock after buying an additional 16,747 shares during the quarter. South Dakota Investment Council’s holdings in Clorox were worth $9,361,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in CLX. Darwin Wealth Management LLC purchased a new position in shares of Clorox in the 2nd quarter worth about $29,000. Caitlin John LLC grew its position in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares during the last quarter. Root Financial Partners LLC grew its position in Clorox by 83.8% during the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after purchasing an additional 145 shares during the last quarter. Vision Financial Markets LLC increased its stake in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. Finally, SHP Wealth Management bought a new stake in Clorox during the 4th quarter valued at about $35,000. 78.53% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on CLX. Jefferies Financial Group downgraded shares of Clorox from a “buy” rating to a “hold” rating and dropped their target price for the stock from $125.00 to $98.00 in a research note on Tuesday. Barclays boosted their price objective on shares of Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a report on Tuesday, July 21st. Citigroup lowered their price objective on Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Evercore reiterated an “underperform” rating and set a $98.00 target price on shares of Clorox in a research note on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $94.00 target price on shares of Clorox in a report on Wednesday, July 22nd. Twelve analysts have rated the stock with a Hold rating and five have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average price target of $101.00.
Insider Transactions at Clorox
In related news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction on Tuesday, May 5th. The stock was acquired at an average price of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.63% of the company’s stock.
Clorox Stock Performance
Shares of NYSE CLX opened at $99.67 on Thursday. The firm’s 50-day moving average price is $95.46 and its 200-day moving average price is $103.79. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $128.90. The company has a market cap of $12.05 billion, a PE ratio of 16.18 and a beta of 0.54. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.
Clorox (NYSE:CLX – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The firm had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s quarterly revenue was up .1% on a year-over-year basis. During the same period in the previous year, the company earned $1.45 earnings per share. As a group, analysts anticipate that The Clorox Company will post 5.52 EPS for the current year.
Clorox Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Read More
- Five stocks we like better than Clorox
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
